Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pathologic diagnosis of any solid tumor
Incurable cancer, with disease progression following at least 1 therapy with no further standard treatment available in the opinion of the investigator.
At least 1 evaluable lesion per RECIST criteria
You may not be if
Clinically unstable primary or metastatic CNS tumors
Subjects with known diabetes
QTc interval greater than 470 ms.
Clareo Health | Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
